Jump Financial, LLC Next Cure, Inc. Transaction History

Jump Financial, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$4.76 - $6.24 $65,212 - $85,488	-13,700 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$5.7 - $9.1 $78,090 - $124,670	13,700 New	13,700 $82,000
Q3 2021 Nov 12, 2021	SELL	$6.74 - $8.02 $113,023 - $134,487	-16,769 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$7.6 - $10.28 $127,444 - $172,385	16,769 New	16,769 $135,000
Q1 2021 May 17, 2021	SELL	$9.81 - $13.88 $181,592 - $256,932	-18,511 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$9.47 - $12.43 $21,885 - $28,725	2,311 Added 14.27%	18,511 $202,000
Q3 2020 Nov 13, 2020	BUY	$8.15 - $21.17 $132,030 - $342,954	16,200 New	16,200 $143,000

15.9M

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $23M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.